Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:beta-Tyrosine)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002551 AN004201 Metabolomics dataset of CNTF induced axon regeneration in mice post optic nerve crush Eye tissue Mouse Eye disease University of Miami µg/ml
ST002775 AN004518 Zebrafish Retina Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Normalized Concentrations
ST002444 AN003981 Zebrafish Optic Nerve Regeneration Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami normalized peak areas
ST002153 AN003526 Data from plasma metabolome analysis of APP-KI and Wild type mice treated with B. breve MCC1274 Blood Mouse Morinaga milk industry CO., LTD. peak area
ST002776 AN004519 Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Peak Area
ST002776 AN004520 Zebrafish Optic Nerve Regeneration, Tectum Metabolomics - 3 Days Post Crush Eye tissue Zebrafish Eye disease University of Miami Peak Area
ST000414 AN000656 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000421 AN000664 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000665 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000421 AN000666 ms3076 T1D poor glycemic control and control samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000422 AN000668 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST000046 AN000079 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000082 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000083 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST002108 AN003449 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST002516 AN004144 Time course 2: Growth of Eggerthella lenta in defined media with some samples receiving 13C2 stable isotope labeled acetate Bacterial culture supernatant Eggerthella lenta University of California, San Francisco relative ion counts
  logo